embolic debris

Tel Aviv, Israel, September 9, 2026 AEYE announced publication of clinical-trial findings evaluating AEYE-DS, an autonomous artificial intelligence-based screening...

San Jose, California, September 9, 2026 Emboline has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its...